Segall Bryant & Hamill LLC Raises Stake in Silicon Laboratories Inc. (NASDAQ:SLAB)

Segall Bryant & Hamill LLC lifted its stake in shares of Silicon Laboratories Inc. (NASDAQ:SLAB) by 17.4% during the fourth quarter, HoldingsChannel.com reports. The firm owned 87,810 shares of the semiconductor company’s stock after purchasing an additional 13,043 shares during the period. Segall Bryant & Hamill LLC’s holdings in Silicon Laboratories were worth $10,908,000 at the end of the most recent reporting period.

A number of other large investors have also made changes to their positions in SLAB. Natixis Advisors LLC grew its position in Silicon Laboratories by 6.2% during the third quarter. Natixis Advisors LLC now owns 12,050 shares of the semiconductor company’s stock worth $1,393,000 after buying an additional 708 shares during the period. Advisors Asset Management Inc. boosted its stake in shares of Silicon Laboratories by 159.4% during the 3rd quarter. Advisors Asset Management Inc. now owns 275 shares of the semiconductor company’s stock worth $32,000 after acquiring an additional 169 shares in the last quarter. Intech Investment Management LLC grew its holdings in shares of Silicon Laboratories by 82.9% in the 3rd quarter. Intech Investment Management LLC now owns 12,837 shares of the semiconductor company’s stock worth $1,484,000 after acquiring an additional 5,818 shares during the period. Citigroup Inc. grew its holdings in shares of Silicon Laboratories by 37.6% in the 3rd quarter. Citigroup Inc. now owns 59,064 shares of the semiconductor company’s stock worth $6,826,000 after acquiring an additional 16,134 shares during the period. Finally, Cerity Partners LLC increased its stake in Silicon Laboratories by 19.0% in the 3rd quarter. Cerity Partners LLC now owns 14,372 shares of the semiconductor company’s stock valued at $1,661,000 after purchasing an additional 2,290 shares in the last quarter.

Insiders Place Their Bets

In related news, Director William G. Bock sold 1,000 shares of the company’s stock in a transaction that occurred on Tuesday, February 18th. The shares were sold at an average price of $149.43, for a total transaction of $149,430.00. Following the completion of the transaction, the director now owns 31,115 shares of the company’s stock, valued at approximately $4,649,514.45. This represents a 3.11 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Navdeep S. Sooch sold 2,360 shares of Silicon Laboratories stock in a transaction on Wednesday, February 5th. The shares were sold at an average price of $149.00, for a total transaction of $351,640.00. Following the completion of the transaction, the director now owns 400,567 shares in the company, valued at approximately $59,684,483. This trade represents a 0.59 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 5,360 shares of company stock valued at $782,610. Insiders own 1.72% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have weighed in on SLAB shares. StockNews.com raised Silicon Laboratories from a “sell” rating to a “hold” rating in a report on Tuesday, March 18th. KeyCorp increased their price objective on shares of Silicon Laboratories from $115.00 to $160.00 and gave the company an “overweight” rating in a research note on Wednesday, January 22nd. Stifel Nicolaus raised their target price on shares of Silicon Laboratories from $135.00 to $145.00 and gave the company a “buy” rating in a report on Monday, January 6th. Susquehanna began coverage on shares of Silicon Laboratories in a report on Tuesday, December 17th. They issued a “neutral” rating and a $130.00 price target on the stock. Finally, Needham & Company LLC reiterated a “buy” rating and issued a $150.00 price target on shares of Silicon Laboratories in a research report on Wednesday, March 12th. Six analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $136.20.

Silicon Laboratories Stock Performance

Shares of NASDAQ SLAB opened at $123.03 on Wednesday. The firm has a market cap of $4.00 billion, a P/E ratio of -20.71 and a beta of 1.15. Silicon Laboratories Inc. has a 1 year low of $94.00 and a 1 year high of $160.00. The firm’s 50 day moving average price is $137.67 and its 200 day moving average price is $123.52.

Silicon Laboratories (NASDAQ:SLAB) last issued its quarterly earnings results on Tuesday, February 4th. The semiconductor company reported ($0.11) earnings per share for the quarter, hitting analysts’ consensus estimates of ($0.11). The company had revenue of $166.25 million for the quarter, compared to analyst estimates of $166.09 million. Silicon Laboratories had a negative return on equity of 10.46% and a negative net margin of 32.69%. The business’s revenue for the quarter was up 91.4% compared to the same quarter last year. During the same quarter in the prior year, the company posted ($1.19) EPS. As a group, equities analysts predict that Silicon Laboratories Inc. will post -0.97 EPS for the current year.

Silicon Laboratories Company Profile

Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.